TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Merck Life Science A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,082,321
|
1,879,713
|
1,387,089 |
| Earnings before taxes |
140,921
|
87,155
|
70,712 |
| Total assets |
480,407
|
348,959
|
343,661 |
| Current assets |
478,078
|
344,278
|
337,210 |
| Current liabilities |
123,027
|
99,139
|
46,985 |
| Equity capital |
357,100
|
248,783
|
295,258 |
| - share capital |
2,979
|
2,994
|
2,752 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
74.3%
|
71.3%
|
85.9% |
| Turnover per employee |
297,474
|
268,530
|
198,156 |
| Profit as a percentage of turnover |
6.8%
|
4.6%
|
5.1% |
| Return on assets (ROA) | |||
| Current ratio |
388.6%
|
347.3%
|
717.7% |
| Return on equity (ROE) |
39.5%
|
35.0%
|
23.9% |
| Change turnover |
212,238
|
370,366
|
330,618 |
| Change turnover % |
11%
|
25%
|
31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.